Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Completed · Phase 3

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.

Key facts

Study ID

NCT00078117

Run by

University of California, Los Angeles

People needed

516

Starts

2003-06-01

Expected to finish

2005-05-01

Last updated by the study team

2017-01-12

Who can join

Age: 15 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Females are not pregnant or lactating
• Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment

Where it is running

• Addiction Research & Treatment Services (ARTS) — Denver, Colorado, United States
• Denver Health & Hospitals Authority — Denver, Colorado, United States
• Hartford Dispensary — Hartford, Connecticut, United States
• Connecticut Counseling Centers — Waterbury, Connecticut, United States
• LI Jewish Health System — Glen Oaks, New York, United States
• New York VA Medical Center — New York, New York, United States
• South Light-Wakeview Clinic — Raleigh, North Carolina, United States
• Coastal Horizons Center, Inc. — Wilmington, North Carolina, United States
• CODA — Portland, Oregon, United States
• Norfolk CSB — Norfolk, Virginia, United States
• Providence Behavioral Health Services — Everett, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.